美股新聞 標題聯播 · 近 24 小時 305 則 · 28 個來源 · 最新 9/20 06:00
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · ARDX近 30 天 0 則 · 第 1 / 1 頁
- Valeris Welcomes Patient Services Veteran Lauren Cole to Lead Commercial Strategy
- Ardelyx (ARDX) Is Down 19.7% After Raising IBSRELA Revenue Guidance And Narrowing Losses
- New Strong Sell Stocks for August 7th
- Ardelyx Inc (ARDX) (Q2 2026) Earnings Call Highlights: Record Revenue of $118M Driven by Strong ...
- Ardelyx (ARDX) Reports Q2 Loss, Lags Revenue Estimates
- Compared to Estimates, Ardelyx (ARDX) Q2 Earnings: A Look at Key Metrics
- Ardelyx Reports Second Quarter 2026 Financial Results and Provides Business Update
- Indivior Pharmaceuticals Inc. (INDV) Q2 Earnings and Revenues Beat Estimates
- Will Ardelyx (ARDX) Report Negative Earnings Next Week? What You Should Know
- New Cross-Study Analysis from Spherix Global Insights Combines Physician, Dietitian and Patient Chart Data to Show Access Barriers Still Curbing Xphozah Uptake Ahead of the TDAPA Cliff
- New Strong Sell Stocks for July 23rd
- Claude AI Says Market is Ignoring Ardelyx (ARDX) Growth Catalysts
- Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。